Identification of abscission checkpoint bodies as structures that regulate ESCRT factors to control abscission timing

  1. Lauren K Strohacker
  2. Douglas R Mackay
  3. Madeline A Whitney
  4. Genevieve C Couldwell
  5. Wesley I Sundquist  Is a corresponding author
  6. Katharine S Ullman  Is a corresponding author
  1. University of Utah, United States
  2. University of Utah School of Medicine, United States

Abstract

The abscission checkpoint regulates the ESCRT membrane fission machinery and thereby delays cytokinetic abscission to protect genomic integrity in response to residual mitotic errors. The checkpoint is maintained by Aurora B kinase, which phosphorylates multiple targets, including CHMP4C, a regulatory ESCRT-III subunit necessary for this checkpoint. We now report the discovery that cytoplasmic abscission checkpoint bodies (ACBs) containing phospho-Aurora B and tri-phospho-CHMP4C develop during an active checkpoint. ACBs are derived from Mitotic Interchromatin Granules (MIGs), transient mitotic structures whose components are housed in splicing-related nuclear speckles during interphase. ACB formation requires CHMP4C, and the ESCRT factor ALIX also contributes. ACB formation is conserved across cell types and under multiple circumstances that activate the checkpoint. Finally, ACBs retain a population of ALIX, and their presence correlates with delayed abscission and delayed recruitment of ALIX to the midbody where it would normally promote abscission. Thus, a cytoplasmic mechanism helps regulate midbody machinery to delay abscission.

Data availability

All data reported in this study are included in source data files for each figure.

Article and author information

Author details

  1. Lauren K Strohacker

    Biochemistry and Oncological Sciences, University of Utah, Salt Lake City, United States
    Competing interests
    No competing interests declared.
  2. Douglas R Mackay

    Oncological Sciences, University of Utah, Salt Lake City, United States
    Competing interests
    No competing interests declared.
  3. Madeline A Whitney

    Oncological Sciences, University of Utah, Salt Lake City, United States
    Competing interests
    No competing interests declared.
  4. Genevieve C Couldwell

    Oncological Sciences, University of Utah, Salt Lake City, United States
    Competing interests
    No competing interests declared.
  5. Wesley I Sundquist

    Department of Biochemistry, University of Utah School of Medicine, Salt Lake City, United States
    For correspondence
    wes@biochem.utah.edu
    Competing interests
    Wesley I Sundquist, Reviewing editor, eLife.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-9988-6021
  6. Katharine S Ullman

    Oncological Sciences, University of Utah, Salt Lake City, United States
    For correspondence
    katharine.ullman@hci.utah.edu
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-3693-2830

Funding

National Institutes of Health (NIH R01GM112080)

  • Wesley I Sundquist
  • Katharine S Ullman

Huntsman Cancer Foundation (CRR award)

  • Wesley I Sundquist
  • Katharine S Ullman

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Copyright

© 2021, Strohacker et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 2,683
    views
  • 407
    downloads
  • 22
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Lauren K Strohacker
  2. Douglas R Mackay
  3. Madeline A Whitney
  4. Genevieve C Couldwell
  5. Wesley I Sundquist
  6. Katharine S Ullman
(2021)
Identification of abscission checkpoint bodies as structures that regulate ESCRT factors to control abscission timing
eLife 10:e63743.
https://doi.org/10.7554/eLife.63743

Share this article

https://doi.org/10.7554/eLife.63743

Further reading

    1. Cancer Biology
    Qianqian Ju, Wenjing Sheng ... Cheng Sun
    Research Article

    TAK1 is a serine/threonine protein kinase that is a key regulator in a wide variety of cellular processes. However, the functions and mechanisms involved in cancer metastasis are still not well understood. Here, we found that TAK1 knockdown promoted esophageal squamous cancer carcinoma (ESCC) migration and invasion, whereas TAK1 overexpression resulted in the opposite outcome. These in vitro findings were recapitulated in vivo in a xenograft metastatic mouse model. Mechanistically, co-immunoprecipitation and mass spectrometry demonstrated that TAK1 interacted with phospholipase C epsilon 1 (PLCE1) and phosphorylated PLCE1 at serine 1060 (S1060). Functional studies revealed that phosphorylation at S1060 in PLCE1 resulted in decreased enzyme activity, leading to the repression of phosphatidylinositol 4,5-bisphosphate (PIP2) hydrolysis. As a result, the degradation products of PIP2 including diacylglycerol (DAG) and inositol IP3 were reduced, which thereby suppressed signal transduction in the axis of PKC/GSK-3β/β-Catenin. Consequently, expression of cancer metastasis-related genes was impeded by TAK1. Overall, our data indicate that TAK1 plays a negative role in ESCC metastasis, which depends on the TAK1-induced phosphorylation of PLCE1 at S1060.

    1. Cancer Biology
    2. Cell Biology
    Rui Hua, Jean X Jiang
    Insight

    Cell crowding causes high-grade breast cancer cells to become more invasive by activating a molecular switch that causes the cells to shrink and spread.